Metraipolis › archive › dc_5b068340e291
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics… — Europe PMC PMID:41338248
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41338248
- DOI
- 10.1002/bcp.70370
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:52:36.903Z
- SHA-256 of the archived text
8bffed71210e8eb4a09bca012d6b9bfd5c079bae63b98706176f6db2563cf7fe- Stable URL of this page
https://metraipolis.com/documento/dc_5b068340e291
How to cite
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics… — Europe PMC PMID:41338248 — Europe PMC (en), https://europepmc.org/article/MED/41338248 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5b068340e291 (Metraipolis archive dc_5b068340e291, sha256 8bffed71210e8eb4a09bca012d6b9bfd5c079bae63b98706176f6db2563cf7fe)
BibTeX
@misc{dc5b068340e291,
title = {CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics… — Europe PMC PMID:41338248},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41338248},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5b068340e291; sha256 8bffed71210e8eb4a09bca012d6b9bfd5c079bae63b98706176f6db2563cf7fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41338248. Agents can read the archived copy with the MCP tool read_document.